Guidelines on hepatitis B and C testing

Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to receive the necessary care and treatment to prevent or delay progression of liver disease.

These are the first WHO guidelines on testing for chronic HBV and HCV infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection.

Key WHO publications

  • The World Health Report
    Expert assessment of global health including statistics. Each report focuses on a particular theme.
  • International Pharmacopoeia
    Collection of quality specifications for pharmaceutical substances and dosage forms, for reference or adaptation by WHO Member States.


  • The African Health Monitor
    Web platform for data and statistics, analysis and synthesis of information to support countries establish national or sub-national health observatories.
  • Public Health Panaroma
    Lessons learned from the field, as well as original research work, to facilitate the use of evidence and good practice for public health action.